Correction: The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow

Detalles Bibliográficos
Autores principales: Lange, Andrzej, Jaskula, Emilia, Lange, Janusz, Dworacki, Grzegorz, Nowak, Dorota, Simiczyjew, Aleksandra, Mordak-Domagala, Monika, Sedzimirska, Mariola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283549/
https://www.ncbi.nlm.nih.gov/pubmed/30521628
http://dx.doi.org/10.1371/journal.pone.0209108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283549/
https://www.ncbi.nlm.nih.gov/pubmed/30521628
http://dx.doi.org/10.1371/journal.pone.0209108

Ejemplares similares